TRESCALA

Serial Number 76559978
606

Registration Progress

Application Filed
Oct 30, 2003
Under Examination
Dec 14, 2004
Approved for Publication
Sep 1, 2004
Published for Opposition
Sep 21, 2004
Registered

Basic Information

Serial Number
76559978
Filing Date
October 30, 2003
Published for Opposition
September 21, 2004
Abandonment Date
December 17, 2007
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 17, 2007
Classes
005

Rights Holder

Pfizer Inc.

03
Address
235 East 42nd Street
New York, NY 100175755

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Christopher N. Bolinger and Arthur Silverstein, Richard Friedman, Cynthia Arellano, Tiffany Trunko, Jennet Walker, Sudipta Rao, Stacey Hallerman, Cindy M. Zelson, Heather McDonald, Jane Ungaro, Warren Zeserman, Romy Corliss and Judy McCool.

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

29 events
Date Code Type Description
Dec 20, 2007 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Dec 20, 2007 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Aug 29, 2007 EX5G S SOU EXTENSION 5 GRANTED
Jun 7, 2007 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 7, 2007 EXT5 S SOU EXTENSION 5 FILED
Nov 14, 2006 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 14, 2006 EXT4 S SOU EXTENSION 4 FILED
Nov 14, 2006 EX4G S SOU EXTENSION 4 GRANTED
Jun 14, 2006 EX3G S SOU EXTENSION 3 GRANTED
May 31, 2006 EEXT I SOU TEAS EXTENSION RECEIVED
May 31, 2006 EXT3 S SOU EXTENSION 3 FILED
Dec 2, 2005 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 2, 2005 EXT2 S SOU EXTENSION 2 FILED
Dec 2, 2005 EX2G S SOU EXTENSION 2 GRANTED
May 26, 2005 EEXT I SOU TEAS EXTENSION RECEIVED
May 26, 2005 EXT1 S SOU EXTENSION 1 FILED
May 26, 2005 EX1G S SOU EXTENSION 1 GRANTED
Jan 5, 2005 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 5, 2005 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 14, 2004 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Sep 21, 2004 PUBO A PUBLISHED FOR OPPOSITION
Sep 1, 2004 NPUB O NOTICE OF PUBLICATION
Jul 9, 2004 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 28, 2004 MAIL I PAPER RECEIVED
Jun 28, 2004 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 28, 2004 ACEC I AMENDMENT FROM APPLICANT ENTERED
May 28, 2004 CNRT F NON-FINAL ACTION MAILED
May 24, 2004 DOCK D ASSIGNED TO EXAMINER
Dec 9, 2003 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, preparations to lower cholesterol, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005